OKUR Valuation

Onkure Therapeutics Inc (OKUR) has a current Price-to-Book (P/B) ratio of 0.63. Compared to its 3-year average P/B ratio of 0.03 , the current P/B ratio is approximately 1904.85% higher. Relative to its 5-year average P/B ratio of 0.03, the current P/B ratio is about 1904.85% higher. Onkure Therapeutics Inc (OKUR) has a Forward Free Cash Flow (FCF) yield of approximately -153.20%. Compared to its 3-year average FCF yield of -117.57%, the current FCF yield is approximately 30.30% lower. Relative to its 5-year average FCF yield of -117.57% , the current FCF yield is about 30.30% lower.